TakeoverAI rollups

STIMNeuronetics, Inc.

1.0×

Top 16% of the Russell 3000. How it works

Makes TMS depression devices and runs Greenbrook clinics delivering in-office treatment sessions.

Deal filings

FiledFormAcquirerPricePremium
Oct 4, 2024DEFM14A—$0.01—
Sep 17, 2024PREM14A—$0.01—

Key numbers

Revenue
—
Operating margin
—
EBITDA
—
Net debt / EBITDA
—

Financials

No XBRL financials yet.